等待開盤 07-01 09:30:00 美东时间
+3.930
+7.71%
今日重点评级关注:Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元;康托·菲茨杰拉德:维持BioCryst制药"超配"评级,目标价从27美元升至29美元
今天 10:40
Shares of Fortune Brands Innovations (FBIN) rose about 2% in the premarket trading on Tuesday after Truist Securities upgraded the stock to Buy from Hold and raised its price target to $70 from $45, s...
06-30 21:18
Fortune Brands Innovations (FBIN) appointed Jesse G. Singh as chief executive officer and a member of its board, effective June 29, 2026. Singh most recently served as CEO of The AZEK Company from 201...
06-29 21:07
From mining to biotech, these companies are exploring strategic alternatives, including a sale, to unlock growth and value.
05-30 02:15
Fortune Brands director Edward P. Garden acquires common shares worth $13,659,652.00 Edward P. Garden, director, reported a shift in Fortune Brands Innovations common stock holdings tied to GI SPV II L.P. and Green 73 LLC. The filing showed 373,741 shares disposed at USD 0, alongside purchases total
05-21 09:30
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从11美元升至12美元;Ladenburg Thalmann:维持Usio"买入"评级,目标价从5.75美元升至6.25美元
05-18 11:48
JP Morgan analyst Michael Rehaut maintains Fortune Brands (NYSE:FBIN) with a Neutral and lowers the price target from $42 to $39.
05-16 00:10
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific May 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, NVIDIA and Thermo Fisher Scientific, on Friday. HIGHLIGHTS * Applied Ma
05-15 15:16
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43